• Independent innovation,
    high-tech enterprise
  • Continuous innovation, protect health
  • Serving the world
AB Pharma

        Shanghai Aibo Pharmaceutical Technology Co., Ltd. is a high-tech enterprise established in the Xinzhuang Industrial Zone of Shanghai, founded by Dr. Zhan Zhengyun, a special expert of the “Thousand Talents Program”. It has a number of independent intellectual property rights; it is mainly developed. Two new anti-hepatitis C virus (HCV) targets, NS3/4A and NS5A"; a new drug (ZN2007) that inhibits the HCV-NS3/4A target, which began clinical trials in the United States in March 2016, The new drug has submitted clinical trial registration application materials to the Chinese Food and Drug Administration CFDA in May this year; another self-developed new drug that inhibits the HCV-NS5A target will also begin clinical trials in the US and China in 2017.

AB Project Planning

AB Pharma

      Hepatitis C (HCV) is the highest mortality rate among viral hepatitis, and its incidence is a global trend. It is the leading cause of end-stage liver disease in countries such as Europe, America and Japan. To date, approximately 200 million people worldwide have been infected with the hepatitis C virus, and China is the country with the largest number of hepatitis C patients.

      According to a recent World Health Organization report, there are about 40 million people with hepatitis C in China. In the national CDC system, about 20,000 new hepatitis C patients are found each year.

Patients with hepatitis C who have not received treatment for a long time can cause cirrhosis and liver cancer and eventually lose their lives. To date, the best treatment for cirrhosis and liver cancer is liver transplantation.

The cost of liver transplantation is high, and the average surgery cost per patient is about 300,000 to 350,000 yuan. Not only that, but a serious problem often encountered in liver transplantation is the lack of liver volunteers and the inability to perform surgery.

Our Business Partners
021-5442 6122
©2018 AB Pharma Ltd. All rights reserved
沪公网安备 33311802006333号 沪ICP备13019832号-1
Technical Support:www.51eway.com
No. 99, Lane 133, Guangzhong Road, Shanghai